Stereotyped patterns of B-cell receptor in splenic marginal zone lymphoma

Haematologica

Volumn 95, Issue 10, 2010, Pages 1792-1796

  Zibellini, Silvia ^a   Capello, Daniela ^b   Forconi, Francesco ^c   Marcatili, Paolo ^d   Rossi, Davide ^b   Rattotti, Sara ^a   Franceschetti, Silvia ^b   Sozzi, Elisa ^c   Cencini, Emanuele ^c   Marasca, Roberto ^e   Baldini, Luca ^f   Tucci, Alessandra ^g   Bertoni, Francesco ^h   Passamonti, Francesco ^a   Orlandi, Ester ^a   Varettoni, Marzia ^a   Merli, Michele ^a   Rizzi, Silvia ^a   Gattei, Valter ⁱ   Tramontano, Anna ^d   Paulli, Marco ⁱ   Gaidano, Gianluca ^b   Arcaini, Luca ^a   more..

^a UNIVERSITY OF PAVIA   (Italy)

^b UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^c UNIVERSITY OF SIENA   (Italy)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

^e UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^f UNIVERSITY OF MILAN   (Italy)

^g Division of Hematology   (Italy)

^h ONCOLOGY INSTITUTE OF SOUTHERN SWITZERLAND   (Switzerland)

ⁱ CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

Author keywords

B cell receptor; Hepatitis c virus; Immunoglobulin genes; Splenic marginal zone lymphoma

Indexed keywords

B LYMPHOCYTE RECEPTOR; IMMUNOGLOBULIN; IMMUNOGLOBULIN HEAVY CHAIN;

ADULT; AGED; ANTIGEN BINDING; ARTICLE; CARCINOGENESIS; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; GENE REARRANGEMENT; HEPATITIS C VIRUS; HUMAN; MAJOR CLINICAL STUDY; MONONUCLEAR CELL; NONHODGKIN LYMPHOMA; OVERALL SURVIVAL; PROGRESSION FREE SURVIVAL; SPLENIC MARGINAL ZONE LYMPHOMA;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS; EPITOPES; GENE REARRANGEMENT; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; LYMPHOMA, B-CELL, MARGINAL ZONE; RECEPTORS, ANTIGEN, B-CELL; SPLENIC NEOPLASMS;

EID: 77957776534     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2010.025437     Document Type: Article

References (24)

1. Swerdlow SH CE, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARC Press, 2008.
2. Matutes E, Oscier D, Montalban C, Berger F, Callet-Bauchu E, Dogan A, et al. Splenic marginal zone lymphoma proposals for a revision of diagnostic, staging and therapeutic criteria. Leukemia. 2008;22(3):487-495.
3. Arcaini L, Lazzarino M, Colombo N, Burcheri S, Boveri E, Paulli M, et al. Splenic marginal zone lymphoma: a prognostic model for clinical use. Blood. 2006; 107(12):4643-4649.
4. Saadoun D, Suarez F, Lefrere F, Valensi F, Mariette X, Aouba A, et al. Splenic lymphoma with villous lymphocytes, associated with type II cryoglobulinemia and HCV infection: a new entity? Blood. 2005; 105(1):74-76.
5. Stamatopoulos K, Belessi C, Papadaki T, Kalagiakou E, Stavroyianni N, Douka V, et al. Immunoglobulin heavy- and light-chain repertoire in splenic marginal zone lymphoma. Mol Med. 2004;10(7-12):89-95.
6. Algara P, Mateo MS, Sanchez-Beato M, Mollejo M, Navas IC, Romero L, et al. Analysis of the IgV(H) somatic mutations in splenic marginal zone lymphoma defines a group of unmutated cases with frequent 7q deletion and adverse clinical course. Blood. 2002;99(4):1299-1304.
7. Zhu D, Orchard J, Oscier DG, Wright DH, Stevenson FK. V(H) gene analysis of splenic marginal zone lymphomas reveals diversity in mutational status and initiation of somatic mutation in vivo. Blood. 2002; 100(7):2659-2661.
8. Tierens A, Delabie J, Malecka A, Wang J, Gruszka-Westwood A, Catovsky D, et al. Splenic marginal zone lymphoma with villous lymphocytes shows on-going immunoglobulin gene mutations. Am J Pathol. 2003;162(2):681-689.
9. Arcaini L, Zibellini S, Passamonti F, Rattotti S, Lucioni M, Invernizzi R, et al. Splenic marginal zone lymphoma: Clinical clustering of immunoglobulin heavy chain repertoires. Blood Cells Mol Dis. 2009;42(3):286-291.
10. Traverse-Glehen A, Davi F, Ben Simon E, Callet-Bauchu E, Felman P, Baseggio L, et al. Analysis of VH genes in marginal zone lymphoma reveals marked heterogeneity between splenic and nodal tumors and suggests the existence of clonal selection. Haematologica. 2005;90(4):470-478.
11. Stamatopoulos K, Belessi C, Moreno C, Boudjograh M, Guida G, Smilevska T, et al. Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: Pathogenetic implications and clinical correlations. Blood. 2007;109(1):259-270.
12. Murray F, Darzentas N, Hadzidimitriou A, Tobin G, Boudjogra M, Scielzo C, et al. Stereotyped patterns of somatic hypermutation in subsets of patients with chronic lymphocytic leukemia: implications for the role of antigen selection in leukemogenesis. Blood. 2008;111(3):1524-1533.
13. Chiorazzi N, Rai KR, Ferrarini M. Chronic lymphocytic leukemia. N Engl J Med. 2005; 352(8):804-815.
14. Forconi F, Sahota SS, Raspadori D, Mockridge CI, Lauria F, Stevenson FK. Tumor cells of hairy cell leukemia express multiple clonally related immunoglobulin isotypes via RNA splicing. Blood. 2001; 98(4):1174-1181.
15. Lefranc MP. IMGT, the International ImMunoGeneTics Information System for Immunoinformatics: methods for querying IMGT databases, tools, and web resources in the context of immunoinformatics. Mol Biotechnol. 2008;40(1):101-111.
16. Larkin MA, Blackshields G, Brown NP, Chenna R, McGettigan PA, McWilliam H, et al. Clustal W and Clustal X version 2.0. Bioinformatics. 2007;23(21):2947-2948.
17. Messmer BT, Albesiano E, Efremov DG, Ghiotto F, Allen SL, Kolitz J, et al. Multiple distinct sets of stereotyped antigen receptors indicate a role for antigen in promoting chronic lymphocytic leukemia. J Exp Med. 2004;200(4):519-525.
18. Rossi D, Spina V, Cerri M, Rasi S, Deambrogi C, De Paoli L, et al. Stereotyped B-cell receptor is an independent risk factor of chronic lymphocytic leukemia transformation to Richter syndrome. Clin Cancer Res. 2009;15(13):4415-4422.
19. Marcatili P, Rosi A, Tramontano A. PIGS: automatic prediction of antibody structures. Bioinformatics. 2008;24(17):1953-1954.
20. Sali A, Blundell TL. Comparative protein modelling by satisfaction of spatial restraints. J Mol Biol. 1993;234(3):779-815.
21. Baker NA, Sept D, Joseph S, Holst MJ, McCammon JA. Electrostatics of nanosystems: application to microtubules and the ribosome. Proc Natl Acad Sci USA. 2001;98(18):10037-10041.
22. Cheson BD, Pfistner B, Juweid ME, Gascoyne RD, Specht L, Horning SJ, et al. Revised response criteria for malignant lymphoma. J Clin Oncol. 2007;25(5):579-586.
23. Al-Lazikani B, Lesk AM, Chothia C. Standard conformations for the canonical structures of immunoglobulins. J Mol Biol. 1997;273(4):927-928.
24. Kyte J, Doolittle RF. A simple method for displaying the hydropathic character of a protein. J Mol Biol. 1982;157(1):105-132.